I-Ring expands pupil, enhances surgical field of view

Pupil expansion devices are an essential element of cataract surgery in cases of non-dilating pupils. An adequately sized capsulorrhexis with an adequate and appropriate exposure of the surgical space ensures the ease of surgery. Without the use of a proper pupil expansion device, a small pupil may cause complications such as sphincter tears, intraoperative bleeding, zonular dialysis and, in extreme cases with prolonged struggle, possibly even posterior capsular rent or nucleus drop. Prolonged surgical time and increased maneuvering may result in postoperative complications such as striate keratopathy, uveitis, secondary glaucoma, floppy iris, torn iris, atrophic iris, irregular pupil, endophthalmitis or cystoid macular edema, all resulting in a suboptimal surgical outcome and an unhappy patient.Currently available devices are designed to be placed either totally intraocularly (rings) or partially externally with the intraocular extension of the device holding back the pupil retracting the iris tissue (iris hooks, Assia pupil expander). The I-Ring is a new pupil expansion device from Beaver-Visitec that is designed to safely expand the iris tissue and enhance the surgeon’s field of view.

ACADIA Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present at the LEERINK Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016, at 8:00 a.m. Eastern Time in New York City. A live webcast of ACADIA’s presentation will be accessible on the company’s webs